COGT
Cogent Biosciences Inc
31.40$
+0.1%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | -7.1% | +34.3% | +1.3% | +1.6% | – | – | +1.7% | – | – | -1.9% | – | – | |
| – | – | -122.2% | – | – | – | -153.0% | – | – | – | – | – | – | |
| – | -2.8% | +8.2% | +3.0% | +17.2% | -2.5% | +1.6% | -3.1% | +13.0% | +7.8% | +1.3% | -6.0% | – | |
| – | +0.6% | +2.0% | +4.1% | +16.9% | -0.9% | +1.8% | +12.4% | +7.4% | +66.6% | +18.0% | +12.7% | – | |
| – | -2.3% | +7.2% | +3.2% | +17.1% | -2.2% | +1.6% | -0.7% | +12.0% | +17.9% | +4.2% | +0.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | +364.6% | -11.7% | -5.9% | +0.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.